Asgard Therapeutics AB
559184-0136ActivePioneering in vivo cell reprogramming for next-generation cancer immunotherapy.
Biotech Company / Pharmaceutical Development Companyasgardthx.com
Yleiskatsaus
- 10–19
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2018
- Perustettu
Avainpäättäjät
Philipp Müller
Board Member (Boehringer Ingelheim Venture Fund)
@asgardthx.com
Ignacio Melero
Clinical Advisory Board Member
@asgardthx.com
Johanna Olweus
Scientific Advisory Board Member
@asgardthx.com
Shane Olwill
Chief Development Officer
@asgardthx.com
+15 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Asgard Therapeutics is a Swedish private biotech company focused on revolutionizing cancer immunotherapy. Their core mission involves pioneering direct cell reprogramming technologies. Specifically, they aim to develop scalable methods for the in vivo conversion of cancer cells into functional antig...
Valo Therapeutics Oy